09877.HK
Jenscare Scientific Co., Ltd.
HKSE · Healthcare · Medical - Specialties · CN
HKD 6.57
+0.77%Year over year
Reported trailing growth
- Revenue
- +1986.6%
- EBITDA
- —
- EBIT
- —
- EPS
- +14.1%
- Free cash flow
- +61.8%
- Operating cash flow
- +60.6%
Forward estimates
Based on analyst estimates
- Revenue
- -54.2%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- -48.8%
- Free cash flow
- +72.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026